1443 related articles for article (PubMed ID: 16552474)
1. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
2. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
3. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
Mocanu MM; Baxter GF; Yue Y; Critz SD; Yellon DM
Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
[TBL] [Abstract][Full Text] [Related]
4. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
5. The significance of the washout period in preconditioning.
Salie R; Lochner A; Loubser DJ
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
[TBL] [Abstract][Full Text] [Related]
6. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
[TBL] [Abstract][Full Text] [Related]
7. CREB activation and ischaemic preconditioning.
Marais E; Genade S; Lochner A
Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
[TBL] [Abstract][Full Text] [Related]
8. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
Lochner A; Marais E; Genade S; Huisamen B; du Toit EF; Moolman JA
Cardiovasc J Afr; 2009; 20(1):43-51. PubMed ID: 19287816
[TBL] [Abstract][Full Text] [Related]
9. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
Lochner A; Genade S; Hattingh S; Marais E; Huisamen B; Moolman JA
Cardiovasc Drugs Ther; 2003 May; 17(3):217-30. PubMed ID: 14574080
[TBL] [Abstract][Full Text] [Related]
10. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.
Bell JR; Eaton P; Shattock MJ
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):126-34. PubMed ID: 17892505
[TBL] [Abstract][Full Text] [Related]
11. The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning.
Marais E; Genade S; Salie R; Huisamen B; Maritz S; Moolman JA; Lochner A
Basic Res Cardiol; 2005 Jan; 100(1):35-47. PubMed ID: 15526116
[TBL] [Abstract][Full Text] [Related]
12. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
[TBL] [Abstract][Full Text] [Related]
13. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
14. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.
Zhao TC; Cheng G; Zhang LX; Tseng YT; Padbury JF
Cardiovasc Res; 2007 Dec; 76(3):473-81. PubMed ID: 17884027
[TBL] [Abstract][Full Text] [Related]
16. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.
Salie R; Moolman JA; Lochner A
Basic Res Cardiol; 2012 Sep; 107(5):281. PubMed ID: 22797560
[TBL] [Abstract][Full Text] [Related]
18. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart.
Yue Y; Qin Q; Cohen MV; Downey JM; Critz SD
Cardiovasc Res; 2002 Aug; 55(3):681-9. PubMed ID: 12160965
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
Weinbrenner C; Liu GS; Cohen MV; Downey JM
J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
[TBL] [Abstract][Full Text] [Related]
20. Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age.
Webster I; Salie R; Marais E; Fan WJ; Maarman G; Huisamen B; Lochner A
BMC Physiol; 2017 Mar; 17(1):3. PubMed ID: 28302152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
